secwatch / observer
8-K filed May 6, 2026, 7:59 PM ET ticker BWA CIK 0000908255
earnings confidence high sentiment positive materiality 0.65

BorgWarner Q1 2026 adjusted EPS $1.24 (+12% YoY); maintains full-year guidance

BORGWARNER INC

2026-Q1 EPS reported $1.16 revenue$3,533,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

BORGWARNER INC reported quarter ended March 31, 2026 results: revenue $3,533 million, net income $242 million, EPS $1.24.

Period
quarter ended March 31, 2026
Revenue
$3,533 million
Net income
$242 million
EPS
$1.24
Result
reported results
Exact text from the filing
one electric vehicle award in South Korea. Production is expected to begin in 2026 and 2027 in China and 2027 in South Korea. First Quarter Highlights: • U.S. GAAP net sales of $3,533 million, an increase of approximately 1% compared with the first quarter of 2025. ◦ Excluding the impact of foreign currencies, organic net sales decreased 4.2% compared with the first
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BORGWARNER INC reported full year 2026 results: revenue $14.0 billion to $14.3 billion. Guidance reaffirmed.

Period
full year 2026
Revenue
$14.0 billion to $14.3 billion
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
light vehicle markets will be down 3% to approximately flat and a decline in the Company’s Battery Energy Systems segment sales. Net sales are expected to be in the range of $14.0 billion to $14.3 billion in 2026, compared with 2025 net sales of approximately $14.3 billion. The Company’s net sales guidance implies a year-over-year change in organic net s
View on SEC.gov

Browse all earnings releases →

BORGWARNER INC filing history →

Source: SEC EDGAR
accession 0000908255-26-000023
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.